Jacobs Levy Equity Management, Inc Neuronetics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $60,492 - $107,382	-28,944 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $412,095 - $655,870	-145,104 Reduced 83.37%	28,944 $88,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $107,907 - $183,748	-27,883 Reduced 13.81%	174,048 $776,000
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $1.08 Million - $2.69 Million	172,987 Added 597.66%	201,931 $1.33 Million
Q1 2021 May 17, 2021	SELL	$10.6 - $21.27 $588,151 - $1.18 Million	-55,486 Reduced 65.72%	28,944 $358,000

Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $675,447 - $1.56 Million	-136,454 Reduced 61.78%	84,430 $938,000
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $402,008 - $1.3 Million	220,884 New	220,884 $1.07 Million
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $184,250 - $647,757	-143,946 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $580,102 - $1.33 Million	143,946 New	143,946 $646,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.